GRANIX

This brand name is authorized in United States.

Active ingredients

The drug GRANIX contains one active pharmaceutical ingredient (API):

1
UNII PVI5M0M1GW - FILGRASTIM
 

Filgrastim causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes.

 
Read more about Filgrastim

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
US FDA, National Drug Code 63459-910, 63459-912, 63459-918, 63459-920

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.